Results 51 to 60 of about 35,915 (205)

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. [PDF]

, 2012
Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data meta-analysis to assess the impact on outcomes of the type, number, and duration of drugs used ...
Alfredo Ponce-de-Leon, Andrea Benedetti, Carlos Pérez-Guzmán, Carlton Evans, Carole D. Mitnick, Chen-Yuan Chiang, Chi Chiu Leung, Christophe Lange, David Ashkin, Dennis Falzon, Dick Menzies, Domingo Palmero, Donald Enarson, Eward D. Chan, Geoffrey Pasvol, Giovanni B. Migliori, Giovanni Sotgiu, H. Simon Schaaf, Helen Cox, Hye-Ryoun Kim, Jae-Joon Yim, Jamie N. Bayona, Janice Westenhouse, Jennifer Flood, Jerome Robert, Jiehui Li, Joey Lancaster, Jose Peña, José Sifuentes-Osornio, Katherine Flanagan, Kathy DeRiemer, Kwonjune J. Seung, Leah G. Jarlsberg, Lena Shah, Lia D'Ambrosio, Madhukar Pai, Marcos Burgos, Maria G. Hollm-Delgado, Maria I. D. Quelapio, Maria L. Garcia-Garcia, Mario H. Vargas, Martie Van der Walt, Masa Narita, Matthew J. Strand, Melissa Bauer, Mercedes C. Becerra, Michael D. Iseman, Monika Avendano, Neel Gandhi, Nguyen Huy Dung, Payam Tabarsi, Philly O'Riordan, Pirett Viiklepp, Reuben M. Granich, Rita Banerjee, Robert van Altena, Rosella Centis, Salmaan Keshavjee, Sarah Royce, Sergey P. Mishustin, Seung-kyu Park, Shama D. Ahuja, Sonya S. Shin, Tae Sun Shim, Thelma E. Tupasi, Timothy H. Holtz, Tjip S. Van der Werf, Vaira Leimane, Vija Riekstina, Wiel C. M. de Lange, Wing Wai Yew, Won-Jung Koh, Yuji Shiraishi   +72 more
core   +9 more sources

Cutaneous non‐tuberculous mycobacterial infections: A retrospective study of 94 cases from Germany

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Cutaneous non‐tuberculous mycobacterial infections (NTM) remain a diagnostic and therapeutic challenge. The aim of this study was to characterize cutaneous NTM infections in Germany over a 24‐year‐period. Patients and Methods 73 patients with cutaneous NTM infections diagnosed at 17 different German University Hospitals from 2000 ...
Luisa Bopp, Nicolai Deresz, Henning Klapproth, Isabelle Suárez, Jonathan Jantsch, Mario Fabri, Esther von Stebut   +6 more
wiley   +1 more source

Pyrazinamide-induced maculopapular rash

Indian Journal of Dermatology, 2010
Pyrazinamide is a commonly used first-line antitubercular drug. Gastric-related adverse drug reactions are common with pyrazinamide. Dermatological manifestations due to pyrazinamide are rare.
Khayyam Khalid, Imam Faisal, Sharma Manju, Pillai K, Behera D   +4 more
doaj  

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance. [PDF]

, 2019
INTRODUCTION: 2018 World Health Organization (WHO) guidelines for the treatment of isoniazid (H)-resistant (Hr) tuberculosis recommend a four-drug regimen: rifampicin (R), ethambutol (E), pyrazinamide (Z) and levofloxacin (Lfx), with or without H ([H]RZE-
Abbara, A, Abubakar, I, Alexander, E, Baker, LV, Barrett, JC, Booth, H, Bothamley, GH, Burgess, H, Cosgrove, C, Creer, DD, Davidson, JA, Dunleavy, A, Francis, M, Grp, LINH-RTBS, Gupta, U, Hamid, S, Harris, RJ, Haselden, BM, Holden, E, Kahr, V, Kon, OM, Kunst, H, Lalor, MK, Lipman, MC, Loebinger, MR, Loutet, MG, Lozewicz, S, Lynn, W, McHugh, TD, Milburn, HJ, Mohiyuddin, T, Palchaudhuri, P, Perrin, FM, Phillips, PPJ, Rahman, A, Schmok, E, Soobratty, MR, Stagg, HR, Taylor, L   +38 more
core   +4 more sources

Persistent Hyperglycaemia and Transient Dysglycaemia in Tuberculosis: Evaluating the Bidirectional Interaction With Type‐2 Diabetes Mellitus and Clinical Outcomes

Tropical Medicine &International Health, EarlyView.
ABSTRACT Introduction Poor glycaemic control, indicated by a haemoglobin A1c (HbA1c) level of 7% or higher, increases the risk of active tuberculosis (TB) in patients with diabetes, while active TB can worsen glucose tolerance and insulin resistance, contributing to type‐2 diabetes mellitus (DM) progression.
Augustine Asare Boadu, Prince Asare, Michelle Yeboah‐Manu, Stephen Osei‐Wusu, Emelia Danso Konadu, Adwoa Asante‐Poku, Yayra Klinogo, Abraham Adjei, Desmond Omane Acheampong, Jane S. Afriyie‐Mensah, Dorothy Yeboah‐Manu, Yacoba Atiase   +11 more
wiley   +1 more source

A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant Mycobacterium tuberculosis

International Journal of Mycobacteriology, 2018
Introduction: Tuberculosis (TB) is a significant cause of morbidity and mortality worldwide. The patient compliance with the long treatment regimens is essential for successful eradication.
Daniel Rueda, Roberto Furukawa, Patricia Fuentes, Germán Comina, Nicolás G Rey De Castro, David Requena, Robert H Gilman, Patricia Sheen, Mirko Zimic   +8 more
doaj   +1 more source

Secondary Tuberculosis of Tonsil case report and literature review [PDF]

, 2012
A case report of secondary tuberculosis of tonsil is being discussed along with review of published literature. This report attempts to draw attention to the fact that Tuberculosis is resurgentdespite excellent chemotherapeutic drugs available.
Ramamoorthy, Geetha, Thiagarajan, Balasubramanian, Ulaganathan, Venkatesan   +2 more
core   +1 more source

Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa [PDF]

, 2010
Tuberculosis (TB) remains a global emergency and is responsible for 1.7 million deaths annually. Widespread global misuse of isoniazid and rifampicin over three decades has resulted in emergence of the ominous spread of multidrug-resistant TB (MDR-TB ...
Abdool Karim, Amor, Balabanova, Caminero, Centers for Disease Control and Prevention, Chan, Chiang, Chiang, Chiang, Churchyard, Dheda, Dravniece, Dubrovina, Elliott, Espinal, Espinal, Espinal, Flament-Saillour, Gandhi, Gandhi, Gandhi, Goble, Grobusch, Habeenzu, Hoek, Holtz, Holtz, Iseman, Johnson, Kehinde, Kim, Kingkaew, Korenromp, Kranzer, Lalloo, Laserson, Lienhardt, Ma, Martin, Matteelli, Meskel, Migliori, Migliori, Migliori, Migliori, Migliori, Moore, Motus, O’Donnell, Pablos-Méndez, Pai, Park, Pietzka, Pillay, Quy, Saravia, Schaaf, Schaaf, Shah, Somocurcio, Sonnenberg, Sotgiu, Torun, Umubyeyi, Wallis, WHO, WHO, WHO and IUATLD, Wright, Wright, Zumla   +70 more
core   +1 more source

Destroyed Lung Syndrome—A Devastating and Neglected Consequence of Pulmonary Tuberculosis: Case Series From a Low‐Resource Setting in Ghana

Clinical Case Reports, Volume 14, Issue 4, April 2026.
Post‐pulmonary TB destroyed lung syndrome. ABSTRACT Tuberculous destroyed lung syndrome is a devastating and often neglected sequela of pulmonary tuberculosis. It has significant adverse effects on the quality of life of affected patients. This case series aims to raise awareness among clinicians and to emphasize the need for multifaceted preventive ...
Prosper Adjei, Kingsley Owusu Manu, Samuel Kyeremeh Adjei, Theophilus Nyamekye Yeboah, Bridget Maame Kweenuwa Ansah, Daniel Kwabena Asare, Fatimata Musah, Safura Alhassan   +7 more
wiley   +1 more source

Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance—India, 2018–2020

Frontiers in Microbiology
Pyrazinamide (PZA) is a key first-line antituberculosis drug that plays an important role in eradicating persister Mycobacterium tuberculosis (TB) bacilli and shortening the duration of tuberculosis treatment.
Sembulingam Tamilzhalagan, Evanslin Santus Justin, Ashok Selvaraj, Karthick Venkateswaran, Arun Kumar Sivakumar, Suganthi Chittibabu, Heather P. McLaughlin, Patrick K. Moonan, Jonathan P. Smith, Sakthi Suba, Mukesh Kumar Sathya Narayanan, Christine S. Ho, Nishant Kumar, Srikanth P. Tripathy, Srikanth P. Tripathy, Siva K. Shanmugam, Patricia J. Hall-Eidson, Uma Devi Ranganathan   +17 more
doaj   +1 more source